A nomogram for individualized estimation of survival among patients with brain metastasis
Author(s) -
Jill S. BarnholtzSloan,
ChengPing Yu,
A. E. Sloan,
Jaime Vengoechea,
M. Wang,
James J. Dignam,
Michael A. Vogelbaum,
Paul W. Sperduto,
Minesh P. Mehta,
Mitchell Machtay,
Michael W. Kattan
Publication year - 2012
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/nos087
Subject(s) - nomogram , medicine , brain metastasis , confidence interval , proportional hazards model , oncology , recursive partitioning , metastasis , radiation therapy , performance status , primary tumor , survival analysis , lung cancer , concordance , cancer
An estimated 24%-45% of patients with cancer develop brain metastases. Individualized estimation of survival for patients with brain metastasis could be useful for counseling patients on clinical outcomes and prognosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom